Hyperactive FOXA1 reprograms endocrine-resistant breast cancer to become metastatic

(Baylor College of Medicine) A team led by researchers at Baylor College of Medicine and Harvard Medical School has unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new therapeutic strategies.